Maximum quantity allowed is 999
CAS RN: 70476-82-3 | Product Number: M3110
Mitoxantrone Dihydrochloride
Purity: >97.0%(HPLC)
- 1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]anthraquinone Dihydrochloride
- 1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]anthracene-9,10-dione Dihydrochloride
| Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time |
Shipping Information
|
|---|---|---|---|---|---|
| 25MG |
$65.00
|
32 | 0 | Contact Us | |
| 100MG |
$190.00
|
10 | ≥40 | Contact Us |
* Please contact our distributors or
TCI
to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.
| Product Number | M3110 |
Purity / Analysis Method
|
>97.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__2__2H__2__8N__4O__6·2HCl = 517.40 |
| Physical State (20 deg.C) | Solid |
Storage Temperature
|
Refrigerated (0-10°C) |
| Condition to Avoid | Heat Sensitive |
Packaging and Container
|
100MG-Glass Bottle with Plastic Insert (View image), 25MG-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 70476-82-3 |
Related CAS RN
|
65271-80-9 |
| Reaxys Registry Number | 4835931 |
| PubChem Substance ID | 468592271 |
| Merck Index (14) | 6217 |
| MDL Number | MFCD00242943 |
| Appearance | Dark green to Dark purple to Black powder to crystal |
| Purity(Argentometric Titration) | min. 95.0 % |
| Purity(HPLC) | min. 97.0 area% |
| NMR | confirm to structure |
| Melting Point | 267 °C(dec.) |
| Maximum Absorption Wavelength | 660 nm (H__2O) |
| Solubility (slightly sol. in) | Methanol |
| Solubility (insoluble in) | Chloroform, Acetone |
| Pictogram |
|
| Signal Word | Danger |
| Hazard Statements | H310 : Fatal in contact with skin. H302 : Harmful if swallowed. H360 : May damage fertility or the unborn child. H362 : May cause harm to breast-fed children. H370 : Causes damage to organs. H372 : Causes damage to organs through prolonged or repeated exposure. H341 : Suspected of causing genetic defects. H351 : Suspected of causing cancer. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P263 : Avoid contact during pregnancy and while nursing. P260 : Do not breathe dust. P270 : Do not eat, drink or smoke when using this product. P262 : Do not get in eyes, on skin, or on clothing. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P311 : IF exposed or concerned: Call a POISON CENTER/doctor. P361 + P364 : Take off immediately all contaminated clothing and wash it before reuse. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. P302 + P352 + P310 : IF ON SKIN: Wash with plenty of water. Immediately call a POISON CENTER/doctor. P405 : Store locked up. |
| RTECS# | CB0386900 |
| UN Number | UN2811 |
| Class | 6.1 |
| Packing Group | II |
| H.S.code* | 2922.50-000 |
References
- Mitoxantrone modulates a heparan sulfate‑spike complex to inhibit SARS‑CoV‑2 infection
- Inhibition of cowpox virus and monkeypox virus infection by mitoxantrone
- Developing a Dynamic Pharmacophore Model for HIV-1 Integrase
- Mitochondrial proliferation during apoptosis induced by anticancer agents: effects of doxorubicin and mitoxantrone on cancer and cardiac cells
- Experimental antitumor activity of aminoanthraquinones
- Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenediones
- Mechanism of Action of Topoisomerase II-Targeted Antineoplastic Drugs
- Mitoxantrone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer
- Mechanism of action of mitoxantrone (a review)
- HPLC analysis of mitoxantrone in mouse plasma and tissues: Application in a pharmacokinetic study
- Mitoxantrone hydrochloride (a review on the description, synthesis, physical properties, stability, pharmacology, and detection)
Reference
References
Documents
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
The requested SDS is not available.
Specifications
The requested specifications are not available.
Please Contact Us for more information.
The requested specifications are not available.
C of A & Other Certificates
Please check that the lot number you have entered is correct. It is 4-5 alphanumeric characters before the hyphen. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
If your information is correct and you are still not able to view the requested certificates, Please Contact Us for more information.
Please check that the lot number you have entered is correct. It is 7 alphanumeric characters. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.